Clinical Trials Logo

Clinical Trial Summary

Breast implants, either cosmetic or reconstructive, are among the most common procedures performed by plastic surgeons. Bacterial infections or biofilms are implicated in the majority of breast implant complications including infection requiring explantation, capsular contracture (CC), and/or breast-implant associated anaplastic large cell lymphoma (BIA-ALCL). The research team, which has already extensively characterized bacterial pathogenesis in the urinary tract and designed non-antibiotic therapeutics to reduce the incidence of catheter-associated urinary tract infections (CAUTIs), and proposal will study bacteria-breast implant interactions and explore further the impact of the breast microbiome. The proposed research provides a greater understanding of which bacteria can colonize breast implants, their source, and how effective antibiotic pocket irrigation is at eliminating them, and begins to examine the mechanisms by which bacteria bind and colonize the implant surface. These insights will set the groundwork for developing new therapeutic agents that can disrupt the binding of certain bacteria to breast implants. Strategies that minimize problems bacteria can cause, while avoiding antibiotics, will reduce bacteria-related implant complications, limit antibiotic-related side effects, and reduce bacterial resistance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03213249
Study type Interventional
Source Washington University School of Medicine
Contact
Status Completed
Phase Phase 1
Start date July 25, 2017
Completion date September 26, 2018

See also
  Status Clinical Trial Phase
Completed NCT03744013 - A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis N/A
Completed NCT00505557 - Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope Phase 1
Active, not recruiting NCT06079086 - Evaluation of the Clinical Evolution of Breast Increase Using Prostheses N/A
Recruiting NCT04307355 - Continuous Diffusion of Oxygen Treatment for Incision Wounds Phase 1/Phase 2
Completed NCT04331080 - A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery Phase 2/Phase 3
Completed NCT01582490 - Study of EXPAREL in Patients Undergoing Breast Augmentation Phase 4